Literature DB >> 21300472

Optimal normal tissue sparing in craniospinal axis irradiation using IMRT with daily intrafractionally modulated junction(s).

Johannes M A M Kusters1, Rob J W Louwe, Peter G M van Kollenburg, Martina C Kunze-Busch, Corrie E M Gidding, Erik J van Lindert, Johannes H A M Kaanders, Geert O R J Janssens.   

Abstract

PURPOSE: To develop a treatment technique for craniospinal irradiation using intensity-modulated radiotherapy (IMRT) with improved dose homogeneity at the field junction(s), increased target volume conformity, and minimized dose to the organs at risk (OARs). METHODS AND MATERIALS: Five patients with high-risk medulloblastoma underwent CT simulation in supine position. For each patient, an IMRT plan with daily intrafractionally modulated junction(s) was generated, as well as a treatment plan based on conventional three-dimensional planning (3DCRT). A dose of 39.6 Gy in 22 daily fractions of 1.8 Gy was prescribed. Dose-volume parameters for target volumes and OARs were compared for the two techniques.
RESULTS: The maximum dose with IMRT was <107% in all patients. V<95 and V>107 were <1 cm3 for IMRT compared with 3-9 cm3 for the craniospinal and 26-43 cm3 for the spinal-spinal junction with 3DCRT. These observations corresponded with a lower homogeneity index and a higher conformity index for the spinal planning target volume with IMRT. IMRT provided considerable sparing of acute and late reacting tissues. V75 for the esophagus, gastroesophageal junction, and intestine was 81%, 81%, and 22% with 3DCRT versus 5%, 0%, and 1% with IMRT, respectively. V75 for the heart and thyroid was 42% and 32% vs. 0% with IMRT.
CONCLUSION: IMRT with daily intrafractionally modulated junction results in a superior target coverage and junction homogeneity compared with 3DCRT. A significant dose reduction can be obtained for acute as well as late-reacting tissues.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21300472     DOI: 10.1016/j.ijrobp.2010.07.1987

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Reducing the dosimetric impact of positional errors in field junctions for craniospinal irradiation using VMAT.

Authors:  Andrej Strojnik; Ignasi Méndez; Primož Peterlin
Journal:  Rep Pract Oncol Radiother       Date:  2016-03-28

2.  Impact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experience.

Authors:  Narendra Kumar; Raviteja Miriyala; Pragyat Thakur; Renu Madan; Pravin Salunke; Budhi Yadav; Ankita Gupta
Journal:  J Neurooncol       Date:  2017-06-02       Impact factor: 4.130

3.  Practical dose delivery verification of craniospinal IMRT.

Authors:  Young K Lee; Anthony T Kim; Peiying Zhao; Aliaksandr Karotki
Journal:  J Appl Clin Med Phys       Date:  2015-11-08       Impact factor: 2.102

4.  Craniospinal irradiation using helical tomotherapy for central nervous system tumors.

Authors:  Sanziana R I Schiopu; Gregor Habl; Matthias Häfner; Sonja Katayama; Klaus Herfarth; Juergen Debus; Florian Sterzing
Journal:  J Radiat Res       Date:  2017-03-01       Impact factor: 2.724

5.  Assessment of the results and hematological side effects of 3D conformal and IMRT/ARC therapies delivered during craniospinal irradiation of childhood tumors with a follow-up period of five years.

Authors:  Zoltán Lőcsei; Róbert Farkas; Kornélia Borbásné Farkas; Klára Sebestyén; Zsolt Sebestyén; Zoltán Musch; Ágnes Vojcek; Noémi Benedek; László Mangel; Gábor Ottóffy
Journal:  BMC Cancer       Date:  2020-07-29       Impact factor: 4.430

6.  Toxicity Reduction after Craniospinal Irradiation via Helical Tomotherapy in Patients with Medulloblastoma: A Unicentric Retrospective Analysis.

Authors:  Anil Öztunali; Khaled Elsayad; Sergiu Scobioala; Mohammed Channaoui; Uwe Haverkamp; Oliver Grauer; Ronald Sträter; Angela Brentrup; Walter Stummer; Kornelius Kerl; Hans Theodor Eich
Journal:  Cancers (Basel)       Date:  2021-01-28       Impact factor: 6.639

Review 7.  Cardiotoxicity of mediastinal radiotherapy.

Authors:  Ivica Ratosa; Maja Ivanetic Pantar
Journal:  Rep Pract Oncol Radiother       Date:  2019-10-30

8.  A simple approach of three-isocenter IMRT planning for craniospinal irradiation.

Authors:  Zheng Wang; Wei Jiang; Yuanming Feng; Yang Guo; Zheng Cong; Bin Song; Yu Guo
Journal:  Radiat Oncol       Date:  2013-09-17       Impact factor: 3.481

9.  Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.

Authors:  Maurice C Cox; Johannes M Kusters; Corrie E Gidding; Jolanda H Schieving; Erik J van Lindert; Johannes H Kaanders; Geert O Janssens
Journal:  Radiat Oncol       Date:  2015-11-24       Impact factor: 3.481

10.  Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting.

Authors:  Michal Devecka; Marciana Nona Duma; Jan J Wilkens; Severin Kampfer; Kai Joachim Borm; Stefan Münch; Christoph Straube; Stephanie E Combs
Journal:  BMC Cancer       Date:  2020-06-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.